A new cancer treatment more potent than the best-selling cancer drug taxol is
working well in human trials. Epothilone, which comes from soil-dwelling
organisms called myxobacteria, stops cancer cells dividing as taxol does. When a
cell splits in two, elastic protein threads draw the chromosomes apart. But
epothilone binds to these “tubulins” and halts a tumour’s runaway cell division.
“Epothilone stops the chromosomes from being pulled apart,” says Herbie Newell
of the Newcastle University Cancer Research Unit.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
Photos reveal unexpected details from the world's first atomic test
3
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
4
We may finally know why dinosaurs like T. rex evolved tiny arms
5
How I used psychology to come back from the worst year of my life
6
The distant world that is our best hope of finding alien life
7
The ‘doomsday’ glacier’s giant ice shelf is about to break away
8
Epic dreaming is leaving people exhausted and distressed
9
Extreme heat hampers children’s early learning
10
CAR T-cell therapy bolstered by stiffening up cancer cells first
